With the aging of the population in western countries, the prevalence of heart valve
disease (HVD) is dramatically increasing and is a clear example of a hidden epidemic
within cardiovascular disease. HVD results in substantial morbidity and mortality
and places a significant burden on already scarce health care resources. However,
outcomes after HVD diagnosis could improve if diagnosed early. The global burden of
HVD, which has historically focused on rheumatic heart disease, has also transitioned
to a greater focus on degenerative HVDs.
1
Nevertheless, with the increase in the immigration rate because of sociopolitical
conflicts and environmental crisis, we might observe an increase in the rate of rheumatic
disease in developed countries.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Burden of valvular heart diseases: a population-based study.Lancet. 2006; 368: 1005-1011
- Global burden of cardiovascular diseases and risk factors. Update from the GBD 2019 study.J Am Coll Cardiol. 2020; 76: 2982-3021
- Older adults and population aging statistics.(Available at:)
- Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.Eur Heart J. 2016; 37: 3515-3522
- Educational series on the specialist valve clinic: challenges in the diagnosis and management of valve disease: the case for the specialist valve clinic.Echo Res Pract. 2019; 6: T1-T6
Article info
Publication history
Published online: January 27, 2023
Accepted:
January 19,
2023
Received:
December 30,
2022
Publication stage
In Press Journal Pre-ProofFootnotes
See page 2 for disclosure information.
Identification
Copyright
© 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
